Literature DB >> 27900568

Control of phosphate balance by the kidney and intestine.

Ichiro Kaneko1, Sawako Tatsumi1, Hiroko Segawa1, Ken-Ichi Miyamoto2.   

Abstract

The prevention and correction of hyperphosphatemia are major goals of the treatment of chronic kidney disease (CKD)-bone mineral disorders, and thus, Pi balance requires special attention. Pi balance is maintained by intestinal absorption, renal excretion, and bone accretion. The kidney is mainly responsible for the plasma Pi concentration. In CKD, reduced glomerular filtration rate leads to various Pi metabolism abnormalities, and Pi absorption in the small intestine also has an important role in Pi metabolism. Disturbances in Pi metabolism are mediated by a series of complex changes in regulatory hormones originating from the skeleton, intestine, parathyroid gland, and kidney. In this review, we describe the regulation of type II sodium-dependent Pi co-transporters by the kidney and intestine, including the regulation of Pi transport, circadian rhythm, and the vicious circle between salivary Pi secretion and intestinal Pi absorption in animals with and without CKD.

Entities:  

Keywords:  1,25(OH)2D; FGF23; Intestine; PTH; Proximal tubule; Salivary glands

Mesh:

Substances:

Year:  2016        PMID: 27900568     DOI: 10.1007/s10157-016-1359-4

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  51 in total

1.  Salivary phosphate-binding chewing gum reduces hyperphosphatemia in dialysis patients.

Authors:  Vincenzo Savica; Lorenzo A Calò; Paolo Monardo; Paul A Davis; Antonio Granata; Domenico Santoro; Rodolfo Savica; Rosa Musolino; Maria Cristina Comelli; Guido Bellinghieri
Journal:  J Am Soc Nephrol       Date:  2008-11-19       Impact factor: 10.121

Review 2.  Phosphate Toxicity in CKD: The Killer among Us.

Authors:  Cynthia S Ritter; Eduardo Slatopolsky
Journal:  Clin J Am Soc Nephrol       Date:  2016-02-10       Impact factor: 8.237

3.  Inorganic phosphate homeostasis in sodium-dependent phosphate cotransporter Npt2b⁺/⁻ mice.

Authors:  Akiko Ohi; Etsuyo Hanabusa; Otoya Ueda; Hiroko Segawa; Naoshi Horiba; Ichiro Kaneko; Shoji Kuwahara; Tomo Mukai; Shohei Sasaki; Rieko Tominaga; Junya Furutani; Fumito Aranami; Shuichi Ohtomo; Yumiko Oikawa; Yousuke Kawase; Naoko A Wada; Takanori Tachibe; Mami Kakefuda; Hiromi Tateishi; Kaoru Matsumoto; Sawako Tatsumi; Shinsuke Kido; Naoshi Fukushima; Kou-Ichi Jishage; Ken-Ichi Miyamoto
Journal:  Am J Physiol Renal Physiol       Date:  2011-08-03

4.  Role of the vitamin D receptor in FGF23 action on phosphate metabolism.

Authors:  Yoshio Inoue; Hiroko Segawa; Ichiro Kaneko; Setsuko Yamanaka; Kenichiro Kusano; Eri Kawakami; Junya Furutani; Mikiko Ito; Masashi Kuwahata; Hitoshi Saito; Naoshi Fukushima; Shigeaki Kato; Hiro-Omi Kanayama; Ken-ichi Miyamoto
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

Review 5.  Salivary glands: a new player in phosphorus metabolism.

Authors:  Vincenzo Savica; Lorenzo A Calò; Domenico Santoro; Paolo Monardo; Giuseppe Santoro; Ugo Muraca; Paul A Davis; Guido Bellinghieri
Journal:  J Ren Nutr       Date:  2011-01       Impact factor: 3.655

6.  Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo.

Authors:  Hitoshi Saito; Akira Maeda; Shu-Ichi Ohtomo; Michinori Hirata; Kenichiro Kusano; Shigeaki Kato; Etsuro Ogata; Hiroko Segawa; Ken-Ichi Miyamoto; Naoshi Fukushima
Journal:  J Biol Chem       Date:  2004-11-05       Impact factor: 5.157

Review 7.  Clinical consequences of mutations in sodium phosphate cotransporters.

Authors:  Eleanor Lederer; Ken-ichi Miyamoto
Journal:  Clin J Am Soc Nephrol       Date:  2012-04-19       Impact factor: 8.237

Review 8.  The osteocyte in CKD: new concepts regarding the role of FGF23 in mineral metabolism and systemic complications.

Authors:  Katherine Wesseling-Perry; Harald Jüppner
Journal:  Bone       Date:  2012-10-16       Impact factor: 4.398

Review 9.  Phosphate transporters of the SLC20 and SLC34 families.

Authors:  Ian C Forster; Nati Hernando; Jürg Biber; Heini Murer
Journal:  Mol Aspects Med       Date:  2013 Apr-Jun

10.  Effect of chitosan chewing gum on reducing serum phosphorus in hemodialysis patients: a multi-center, randomized, double-blind, placebo-controlled trial.

Authors:  Tadao Akizawa; Yoshinari Tsuruta; Yoichi Okada; Yoshihiro Miyauchi; Akio Suda; Hiroshi Kasahara; Nobuhiro Sasaki; Yoshitaka Maeda; Takako Suzuki; Noriaki Matsui; Jun Niwayama; Toshiaki Suzuki; Hideaki Hara; Yasushi Asano; Sadao Komemushi; Masafumi Fukagawa
Journal:  BMC Nephrol       Date:  2014-06-25       Impact factor: 2.388

View more
  9 in total

1.  Prenatal hyperechogenic kidneys in three cases of infantile hypercalcemia associated with SLC34A1 mutations.

Authors:  Marguerite Hureaux; Arnaud Molin; Nadine Jay; Anne Hélène Saliou; Emmanuel Spaggiari; Rémi Salomon; Alexandra Benachi; Rosa Vargas-Poussou; Laurence Heidet
Journal:  Pediatr Nephrol       Date:  2018-06-29       Impact factor: 3.714

2.  An introduction to CKD-MBD research: restart for the future.

Authors:  Masafumi Fukagawa; Masaaki Inaba; Keitaro Yokoyama; Takashi Shigematsu; Ryoichi Ando; Ken-Ichi Miyamoto
Journal:  Clin Exp Nephrol       Date:  2017-03       Impact factor: 2.801

3.  Digenic Heterozygous Mutations in SLC34A3 and SLC34A1 Cause Dominant Hypophosphatemic Rickets with Hypercalciuria.

Authors:  Rebecca J Gordon; Dong Li; Daniel Doyle; Joshua Zaritsky; Michael A Levine
Journal:  J Clin Endocrinol Metab       Date:  2020-07-01       Impact factor: 5.958

4.  Targeted Disruption of a Proximal Tubule-Specific TMEM174 Gene in Mice Causes Hyperphosphatemia and Vascular Calcification.

Authors:  Shinobu Miyazaki-Anzai; Audrey L Keenan; Judith Blaine; Makoto Miyazaki
Journal:  J Am Soc Nephrol       Date:  2022-04-22       Impact factor: 14.978

5.  Effect of Osteocyte-Ablation on Inorganic Phosphate Metabolism: Analysis of Bone-Kidney-Gut Axis.

Authors:  Osamu Fujii; Sawako Tatsumi; Mao Ogata; Tomohiro Arakaki; Haruna Sakaguchi; Kengo Nomura; Atsumi Miyagawa; Kayo Ikuta; Ai Hanazaki; Ichiro Kaneko; Hiroko Segawa; Ken-Ichi Miyamoto
Journal:  Front Endocrinol (Lausanne)       Date:  2017-12-21       Impact factor: 5.555

6.  Role of sodium-dependent Pi transporter/Npt2c on Pi homeostasis in klotho knockout mice different properties between juvenile and adult stages.

Authors:  Ai Hanazaki; Kayo Ikuta; Shohei Sasaki; Sumire Sasaki; Megumi Koike; Kazuya Tanifuji; Yuki Arima; Ichiro Kaneko; Yuji Shiozaki; Sawako Tatsumi; Tomoka Hasegawa; Norio Amizuka; Ken-Ichi Miyamoto; Hiroko Segawa
Journal:  Physiol Rep       Date:  2020-02

7.  Dietary intake of inorganic phosphorus has a stronger influence on vascular-endothelium function than organic phosphorus.

Authors:  Hiromi Kawamura; Sarasa Tanaka; Yuri Ota; Sumire Endo; Mariko Tani; Midori Ishitani; Motoyoshi Sakaue; Mikiko Ito
Journal:  J Clin Biochem Nutr       Date:  2018-01-19       Impact factor: 3.114

8.  Interaction between serum FGF-23 and PTH in renal phosphate excretion, a case-control study in hypoparathyroid patients.

Authors:  Forough Saki; Seyed Reza Kassaee; Azita Salehifar; Gholam Hossein Ranjbar Omrani
Journal:  BMC Nephrol       Date:  2020-05-12       Impact factor: 2.388

9.  FGF23 and Fetuin-A Interaction in the Liver and in the Circulation.

Authors:  Deborah Mattinzoli; Masami Ikehata; Koji Tsugawa; Carlo M Alfieri; Paola Dongiovanni; Elena Trombetta; Luca Valenti; Aldamaria Puliti; Lorenza Lazzari; Piergiorgio Messa
Journal:  Int J Biol Sci       Date:  2018-04-25       Impact factor: 6.580

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.